A human primary airway microphysiological system infected with SARS-CoV-2 distinguishes the treatment efficacy between nirmatrelvir and repurposed compounds fluvoxamine and amodiaquine https://www.biorxiv.org/content/10.1101/2023.06.27.546790v1?med=mas